Matinas biopharma to participate in the h.c. wainwright global investment conference

Bedminster, n.j., sept. 06, 2023 (globe newswire) -- matinas biopharma holdings, inc. (nyse american: mtnb), a clinical-stage biopharmaceutical company focused on redefining the intracellular delivery of nucleic acids and small molecules with its lipid nanocrystal (lnc) platform technology, announces that jerome d. jabbour, chief executive officer, will hold meetings with institutional investors during the h.c. wainwright 25th annual global investment conference being held september 11-13, 2023.
MTNB Ratings Summary
MTNB Quant Ranking